Straight from the Desk
Syz the moment
Live feeds, charts, breaking stories, all day long.
- All
- equities
- United States
- Macroeconomics
- Food for Thoughts
- markets
- Central banks
- Fixed Income
- bitcoin
- Asia
- europe
- investing
- geopolitics
- gold
- technical analysis
- Commodities
- Crypto
- AI
- Technology
- nvidia
- ETF
- earnings
- Forex
- china
- Real Estate
- oil
- banking
- Volatility
- energy
- magnificent-7
- apple
- Alternatives
- emerging-markets
- switzerland
- tesla
- United Kingdom
- Middle East
- amazon
- assetmanagement
- microsoft
- russia
- ethereum
- ESG
- meta
- Industrial-production
- bankruptcy
- Healthcare
- Turkey
- Global Markets Outlook
- africa
- Market Outlook
- brics
- performance
Worst quarter for US stocks relative to the rest of the world in 23 years
Source: Bloomberg Opinion, www.zerohedge.com
Since Trump’s second term began, the US $SPY is trailing Germany $EWG by more than 19 percentage points and China $MCHI by more than 24 percentage points.
A steep hill to climb already for those keeping score. Source: Bespoke @bespokeinvest
This is a very important chart.
Leveraged loans have already broken down. Will junk bonds start to roll over as well? Source: Bloomberg, Crescat Capital
Economic miracle in poland...
This took place in just ONE generation... No secret sauce: Free market, hard work and entrepreneurial spirit. Source: Michel A.Arouet
White paper outlines more than 101 million Indians diagnosed with diabetes and 136 million with pre-diabetes.
Total diabetes treatment cost is projected to hit $12.8 billion by 2030, it said urging government action to curb hashtag#India's growing burden. Read more at: https://lnkd.in/eG_dSUDa
$4.5 Trillion set to expire for today's options expiration. The majority of that are puts!
source: barchart
The OECD published its latest economic outlook on Monday, downgrading its global growth projections for 2025 and 2026 in light of various political and economic uncertainties.
Source: Statista
Investing with intelligence
Our latest research, commentary and market outlooks

